Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

After hours: March 14 at 7:57:16 PM EDT Loading Chart for VERV ...

The companies selected for inclusion have been reviewed and appear to be legitimate, but readers should always perform their own diligence. Please let us know if you believe we should not include ...

The company Rochdale Online Ltd has ceased trading. The company has instructed an insolvency practitioner to commence liquidation procedures. This website will not be updated. Neil Emmott is the ...